Global Head and Neck Cancer Drug Pipeline Capsule - 2012

Fore Pharma, January 2012, Pages: 13

Fore Pharma’s latest report ‘Global Head and Neck Cancer Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global head and neck cancer drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the head and neck cancer drug market is thoroughly covered by company and licensee with the deal summary.

Key Features of the Report:
- Head and Neck Cancer: Overview
- Head and Neck Cancer Drug Pipeline Overview
- Head and Neck Cancer Phase 3 Clinical Trial Drug Pipeline Insights
- Head and Neck Cancer Phase 2 Clinical Trial Drug Pipeline Insights
- Head and Neck Cancer Phase 1 Clinical Trial Drug Pipeline Insights
- Head and Neck Cancer Preclinical Research Drug Pipeline Insights
- Head and Neck Cancer Drug Discovery Pipeline Insights
- Geographic Landscape of Head and Neck Cancer R&D Activities
- Head and Neck Cancer R&D Activities in North America
- Head and Neck Cancer R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Head and Neck Cancer Drug Market

1. Head and Neck Cancer: Disease Definition
2. Head and Neck Cancer Drug Pipeline Overview
3. Head and Neck Cancer Phase 3 Clinical Trial Drug Pipeline Insights
4. Head and Neck Cancer Phase 2 Clinical Trial Drug Pipeline Insights
5. Head and Neck Cancer Phase 1 Clinical Trial Drug Pipeline Insights
6. Head and Neck Cancer Preclinical Research Drug Pipeline Insights
7. Head and Neck Cancer Drug Discovery Pipeline Insights
8. Geographic Landscape of Head and Neck Cancer R&D Activities
8.1 Head and Neck Cancer R&D Activities in North America
8.2 Head and Neck Cancer R&D Activities in Europe
9 Licensing Activities / Partnerships in the Global Head and Neck Cancer Drug Market
10 Research Methodology
Table 1: Head and Neck Cancer Drug Pipeline: Phase 3 Clinical Trial
Table 2: Head and Neck Cancer Drug Pipeline: Phase 2 Clinical Trial
Table 3: Head and Neck Cancer Drug Pipeline: Phase 1 Molecules
Table 4: Head and Neck Cancer Drug Pipeline: Preclinical Research
Table 5: Head and Neck Cancer R&D Activities by Geography
Table 6: Head and Neck Cancer Drug Pipeline: North America
Table 7: Head and Neck Cancer Drug Pipeline: Europe
Table 8: Head and Neck Cancer Drug Pipeline: Licensing Activities
Figure 1 : Head and Neck Cancer Drug Pipeline Molecules by Stages
Figure 2 : Head and Neck Cancer R&D Activities by Geography

Customers who bought this item also bought

• Global Head and Neck Cancer Drug Pipeline Capsule - 2012 Update
• Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2012
• Global Oncology Drug Pipeline Capsule – 2012
• Global Head and Neck Cancer Drug Pipeline Capsule - 2011
• Oncology Partnering Terms and Agreements
• Head And Neck Cancer - Pipeline Review, H2 2012
• Global Ovarian Cancer Drug Pipeline Capsule - 2012 Update
• Global Pancreatic Cancer Drug Pipeline Capsule - 2012 Update
• Global Renal Cancer Drug Pipeline Capsule - 2012 Update
• Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update